| B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen I Puga, M Cols, CM Barra, B He, L Cassis, M Gentile, L Comerma, ... Nature immunology 13 (2), 170-180, 2012 | 827 | 2012 |
| Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (6), 311-335, 2017 | 672 | 2017 |
| Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals M Shan, M Gentile, JR Yeiser, AC Walland, VU Bornstein, K Chen, B He, ... Science 342 (6157), 447-453, 2013 | 626 | 2013 |
| Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (5), 235-251, 2017 | 603 | 2017 |
| Immune-related gene expression profiling after PD-1 blockade in non–small cell lung carcinoma, head and neck squamous cell carcinoma, and melanoma A Prat, A Navarro, L Paré, N Reguart, P Galván, T Pascual, A Martínez, ... Cancer research 77 (13), 3540-3550, 2017 | 387 | 2017 |
| Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells G Magri, M Miyajima, S Bascones, A Mortha, I Puga, L Cassis, CM Barra, ... Nature immunology 15 (4), 354-364, 2014 | 309 | 2014 |
| Human secretory IgM emerges from plasma cells clonally related to gut memory B cells and targets highly diverse commensals G Magri, L Comerma, M Pybus, J Sintes, D Lligé, D Segura-Garzón, ... Immunity 47 (1), 118-134. e8, 2017 | 184 | 2017 |
| Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer Z Kos, E Roblin, RS Kim, S Michiels, BD Gallas, W Chen, KK van de Vijver, ... NPJ breast cancer 6 (1), 17, 2020 | 128 | 2020 |
| Report on computational assessment of tumor infiltrating lymphocytes from the International Immuno-Oncology Biomarker Working Group M Amgad, ES Stovgaard, E Balslev, J Thagaard, W Chen, S Dudgeon, ... NPJ breast cancer 6 (1), 16, 2020 | 117 | 2020 |
| Secreted IgD amplifies humoral T helper 2 cell responses by binding basophils via galectin-9 and CD44 M Shan, J Carrillo, A Yeste, C Gutzeit, D Segura-Garzon, AC Walland, ... Immunity 49 (4), 709-724. e8, 2018 | 88 | 2018 |
| Activation of the BMP4 pathway and early expression of CDX2 characterize non-specialized columnar metaplasia in a human model of Barrett’s esophagus D Castillo, S Puig, M Iglesias, A Seoane, C de Bolós, V Munitiz, P Parrilla, ... Journal of Gastrointestinal Surgery 16 (2), 227-237, 2012 | 63 | 2012 |
| mTOR intersects antibody-inducing signals from TACI in marginal zone B cells J Sintes, M Gentile, S Zhang, Y Garcia-Carmona, G Magri, L Cassis, ... Nature communications 8 (1), 1462, 2017 | 59 | 2017 |
| Glutamine-directed migration of cancer-activated fibroblasts facilitates epithelial tumor invasion A Mestre-Farrera, M Bruch-Oms, R Peńa, J Rodríguez-Morató, ... Cancer Research 81 (2), 438-451, 2021 | 40 | 2021 |
| High Numbers of Circulating CD57+ NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2+ Primary Breast Cancer A Muntasell, S Servitja, M Cabo, B Bermejo, S Pérez-Buira, F Rojo, ... Cancer Immunology Research 7 (8), 1280-1292, 2019 | 32 | 2019 |
| Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials J Hudeček, L Voorwerk, M van Seijen, I Nederlof, M de Maaker, ... NPJ Breast Cancer 6 (1), 15, 2020 | 27 | 2020 |
| LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer I Pérez-Núńez, C Rozalén, JÁ Palomeque, I Sangrador, M Dalmau, ... Nature cancer 3 (3), 355-370, 2022 | 26 | 2022 |
| Coordinated signals from PARP-1 and PARP-2 are required to establish a proper T cell immune response to breast tumors in mice L Moreno-Lama, MA Galindo-Campos, C Martínez, L Comerma, ... Oncogene 39 (13), 2835-2843, 2020 | 19 | 2020 |
| LMO2-negative expression predicts the presence of MYC translocations in aggressive B-cell lymphomas L Colomo, I Vazquez, N Papaleo, B Espinet, A Ferrer, C Franco, ... The American Journal of Surgical Pathology 41 (7), 877-886, 2017 | 19 | 2017 |
| CD137 costimulation counteracts TGFβ inhibition of NK-cell antitumor function M Cabo, S Santana-Hernández, M Costa-Garcia, A Rea, ... Cancer Immunology Research 9 (12), 1476-1490, 2021 | 16 | 2021 |
| Differences in breast cancer risk after benign breast disease by type of screening diagnosis J Louro, M Román, M Posso, L Comerma, C Vidal, F Saladié, R Alcantara, ... The Breast 54, 343-348, 2020 | 16 | 2020 |
